Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Gene Therapy for CNS Disorders Revenue 1.4 Market Analysis by Type 1.4.1 Global Gene Therapy for CNS Disorders Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Ex Vivo 1.4.3 In Vivo 1.5 Market by Application 1.5.1 Global Gene Therapy for CNS Disorders Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Gene Therapy for CNS Disorders Market Perspective (2015-2026) 2.2 Gene Therapy for CNS Disorders Growth Trends by Regions 2.2.1 Gene Therapy for CNS Disorders Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Gene Therapy for CNS Disorders Historic Market Share by Regions (2015-2020) 2.2.3 Gene Therapy for CNS Disorders Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Gene Therapy for CNS Disorders Market Growth Strategy 2.3.6 Primary Interviews with Key Gene Therapy for CNS Disorders Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Gene Therapy for CNS Disorders Players by Market Size 3.1.1 Global Top Gene Therapy for CNS Disorders Players by Revenue (2015-2020) 3.1.2 Global Gene Therapy for CNS Disorders Revenue Market Share by Players (2015-2020) 3.1.3 Global Gene Therapy for CNS Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Gene Therapy for CNS Disorders Market Concentration Ratio 3.2.1 Global Gene Therapy for CNS Disorders Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Gene Therapy for CNS Disorders Revenue in 2019 3.3 Gene Therapy for CNS Disorders Key Players Head office and Area Served 3.4 Key Players Gene Therapy for CNS Disorders Product Solution and Service 3.5 Date of Enter into Gene Therapy for CNS Disorders Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Gene Therapy for CNS Disorders Historic Market Size by Type (2015-2020) 4.2 Global Gene Therapy for CNS Disorders Forecasted Market Size by Type (2021-2026) 5 Gene Therapy for CNS Disorders Breakdown Data by Application (2015-2026) 5.1 Global Gene Therapy for CNS Disorders Market Size by Application (2015-2020) 5.2 Global Gene Therapy for CNS Disorders Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Gene Therapy for CNS Disorders Market Size (2015-2020) 6.2 Gene Therapy for CNS Disorders Key Players in North America (2019-2020) 6.3 North America Gene Therapy for CNS Disorders Market Size by Type (2015-2020) 6.4 North America Gene Therapy for CNS Disorders Market Size by Application (2015-2020) 7 Europe 7.1 Europe Gene Therapy for CNS Disorders Market Size (2015-2020) 7.2 Gene Therapy for CNS Disorders Key Players in Europe (2019-2020) 7.3 Europe Gene Therapy for CNS Disorders Market Size by Type (2015-2020) 7.4 Europe Gene Therapy for CNS Disorders Market Size by Application (2015-2020) 8 China 8.1 China Gene Therapy for CNS Disorders Market Size (2015-2020) 8.2 Gene Therapy for CNS Disorders Key Players in China (2019-2020) 8.3 China Gene Therapy for CNS Disorders Market Size by Type (2015-2020) 8.4 China Gene Therapy for CNS Disorders Market Size by Application (2015-2020) 9 Japan 9.1 Japan Gene Therapy for CNS Disorders Market Size (2015-2020) 9.2 Gene Therapy for CNS Disorders Key Players in Japan (2019-2020) 9.3 Japan Gene Therapy for CNS Disorders Market Size by Type (2015-2020) 9.4 Japan Gene Therapy for CNS Disorders Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Gene Therapy for CNS Disorders Market Size (2015-2020) 10.2 Gene Therapy for CNS Disorders Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Gene Therapy for CNS Disorders Market Size by Type (2015-2020) 10.4 Southeast Asia Gene Therapy for CNS Disorders Market Size by Application (2015-2020) 11 India 11.1 India Gene Therapy for CNS Disorders Market Size (2015-2020) 11.2 Gene Therapy for CNS Disorders Key Players in India (2019-2020) 11.3 India Gene Therapy for CNS Disorders Market Size by Type (2015-2020) 11.4 India Gene Therapy for CNS Disorders Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Gene Therapy for CNS Disorders Market Size (2015-2020) 12.2 Gene Therapy for CNS Disorders Key Players in Central & South America (2019-2020) 12.3 Central & South America Gene Therapy for CNS Disorders Market Size by Type (2015-2020) 12.4 Central & South America Gene Therapy for CNS Disorders Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Gilead (Kite Pharma) 13.1.1 Gilead (Kite Pharma) Company Details 13.1.2 Gilead (Kite Pharma) Business Overview and Its Total Revenue 13.1.3 Gilead (Kite Pharma) Gene Therapy for CNS Disorders Introduction 13.1.4 Gilead (Kite Pharma) Revenue in Gene Therapy for CNS Disorders Business (2015-2020)) 13.1.5 Gilead (Kite Pharma) Recent Development 13.2 Amgen (BioVex) 13.2.1 Amgen (BioVex) Company Details 13.2.2 Amgen (BioVex) Business Overview and Its Total Revenue 13.2.3 Amgen (BioVex) Gene Therapy for CNS Disorders Introduction 13.2.4 Amgen (BioVex) Revenue in Gene Therapy for CNS Disorders Business (2015-2020) 13.2.5 Amgen (BioVex) Recent Development 13.3 Novartis 13.3.1 Novartis Company Details 13.3.2 Novartis Business Overview and Its Total Revenue 13.3.3 Novartis Gene Therapy for CNS Disorders Introduction 13.3.4 Novartis Revenue in Gene Therapy for CNS Disorders Business (2015-2020) 13.3.5 Novartis Recent Development 13.4 Roche (Spark Therapeutics) 13.4.1 Roche (Spark Therapeutics) Company Details 13.4.2 Roche (Spark Therapeutics) Business Overview and Its Total Revenue 13.4.3 Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Introduction 13.4.4 Roche (Spark Therapeutics) Revenue in Gene Therapy for CNS Disorders Business (2015-2020) 13.4.5 Roche (Spark Therapeutics) Recent Development 13.5 Bluebird Bio 13.5.1 Bluebird Bio Company Details 13.5.2 Bluebird Bio Business Overview and Its Total Revenue 13.5.3 Bluebird Bio Gene Therapy for CNS Disorders Introduction 13.5.4 Bluebird Bio Revenue in Gene Therapy for CNS Disorders Business (2015-2020) 13.5.5 Bluebird Bio Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Gene Therapy for CNS Disorders Key Market Segments Table 2. Key Players Covered: Ranking by Gene Therapy for CNS Disorders Revenue Table 3. Ranking of Global Top Gene Therapy for CNS Disorders Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Gene Therapy for CNS Disorders Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Ex Vivo Table 6. Key Players of In Vivo Table 7. Global Gene Therapy for CNS Disorders Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Gene Therapy for CNS Disorders Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Gene Therapy for CNS Disorders Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Gene Therapy for CNS Disorders Market Share by Regions (2015-2020) Table 11. Global Gene Therapy for CNS Disorders Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Gene Therapy for CNS Disorders Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Gene Therapy for CNS Disorders Market Growth Strategy Table 17. Main Points Interviewed from Key Gene Therapy for CNS Disorders Players Table 18. Global Gene Therapy for CNS Disorders Revenue by Players (2015-2020) (Million US$) Table 19. Global Gene Therapy for CNS Disorders Market Share by Players (2015-2020) Table 20. Global Top Gene Therapy for CNS Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for CNS Disorders as of 2019) Table 21. Global Gene Therapy for CNS Disorders by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Gene Therapy for CNS Disorders Product Solution and Service Table 24. Date of Enter into Gene Therapy for CNS Disorders Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Gene Therapy for CNS Disorders Market Size by Type (2015-2020) (Million US$) Table 27. Global Gene Therapy for CNS Disorders Market Size Share by Type (2015-2020) Table 28. Global Gene Therapy for CNS Disorders Revenue Market Share by Type (2021-2026) Table 29. Global Gene Therapy for CNS Disorders Market Size Share by Application (2015-2020) Table 30. Global Gene Therapy for CNS Disorders Market Size by Application (2015-2020) (Million US$) Table 31. Global Gene Therapy for CNS Disorders Market Size Share by Application (2021-2026) Table 32. North America Key Players Gene Therapy for CNS Disorders Revenue (2019-2020) (Million US$) Table 33. North America Key Players Gene Therapy for CNS Disorders Market Share (2019-2020) Table 34. North America Gene Therapy for CNS Disorders Market Size by Type (2015-2020) (Million US$) Table 35. North America Gene Therapy for CNS Disorders Market Share by Type (2015-2020) Table 36. North America Gene Therapy for CNS Disorders Market Size by Application (2015-2020) (Million US$) Table 37. North America Gene Therapy for CNS Disorders Market Share by Application (2015-2020) Table 38. Europe Key Players Gene Therapy for CNS Disorders Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Gene Therapy for CNS Disorders Market Share (2019-2020) Table 40. Europe Gene Therapy for CNS Disorders Market Size by Type (2015-2020) (Million US$) Table 41. Europe Gene Therapy for CNS Disorders Market Share by Type (2015-2020) Table 42. Europe Gene Therapy for CNS Disorders Market Size by Application (2015-2020) (Million US$) Table 43. Europe Gene Therapy for CNS Disorders Market Share by Application (2015-2020) Table 44. China Key Players Gene Therapy for CNS Disorders Revenue (2019-2020) (Million US$) Table 45. China Key Players Gene Therapy for CNS Disorders Market Share (2019-2020) Table 46. China Gene Therapy for CNS Disorders Market Size by Type (2015-2020) (Million US$) Table 47. China Gene Therapy for CNS Disorders Market Share by Type (2015-2020) Table 48. China Gene Therapy for CNS Disorders Market Size by Application (2015-2020) (Million US$) Table 49. China Gene Therapy for CNS Disorders Market Share by Application (2015-2020) Table 50. Japan Key Players Gene Therapy for CNS Disorders Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Gene Therapy for CNS Disorders Market Share (2019-2020) Table 52. Japan Gene Therapy for CNS Disorders Market Size by Type (2015-2020) (Million US$) Table 53. Japan Gene Therapy for CNS Disorders Market Share by Type (2015-2020) Table 54. Japan Gene Therapy for CNS Disorders Market Size by Application (2015-2020) (Million US$) Table 55. Japan Gene Therapy for CNS Disorders Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Gene Therapy for CNS Disorders Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Gene Therapy for CNS Disorders Market Share (2019-2020) Table 58. Southeast Asia Gene Therapy for CNS Disorders Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Gene Therapy for CNS Disorders Market Share by Type (2015-2020) Table 60. Southeast Asia Gene Therapy for CNS Disorders Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Gene Therapy for CNS Disorders Market Share by Application (2015-2020) Table 62. India Key Players Gene Therapy for CNS Disorders Revenue (2019-2020) (Million US$) Table 63. India Key Players Gene Therapy for CNS Disorders Market Share (2019-2020) Table 64. India Gene Therapy for CNS Disorders Market Size by Type (2015-2020) (Million US$) Table 65. India Gene Therapy for CNS Disorders Market Share by Type (2015-2020) Table 66. India Gene Therapy for CNS Disorders Market Size by Application (2015-2020) (Million US$) Table 67. India Gene Therapy for CNS Disorders Market Share by Application (2015-2020) Table 68. Central & South America Key Players Gene Therapy for CNS Disorders Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Gene Therapy for CNS Disorders Market Share (2019-2020) Table 70. Central & South America Gene Therapy for CNS Disorders Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Gene Therapy for CNS Disorders Market Share by Type (2015-2020) Table 72. Central & South America Gene Therapy for CNS Disorders Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Gene Therapy for CNS Disorders Market Share by Application (2015-2020) Table 74. Gilead (Kite Pharma) Company Details Table 75. Gilead (Kite Pharma) Business Overview Table 76. Gilead (Kite Pharma) Product Table 77. Gilead (Kite Pharma) Revenue in Gene Therapy for CNS Disorders Business (2015-2020) (Million US$) Table 78. Gilead (Kite Pharma) Recent Development Table 79. Amgen (BioVex) Company Details Table 80. Amgen (BioVex) Business Overview Table 81. Amgen (BioVex) Product Table 82. Amgen (BioVex) Revenue in Gene Therapy for CNS Disorders Business (2015-2020) (Million US$) Table 83. Amgen (BioVex) Recent Development Table 84. Novartis Company Details Table 85. Novartis Business Overview Table 86. Novartis Product Table 87. Novartis Revenue in Gene Therapy for CNS Disorders Business (2015-2020) (Million US$) Table 88. Novartis Recent Development Table 89. Roche (Spark Therapeutics) Company Details Table 90. Roche (Spark Therapeutics) Business Overview Table 91. Roche (Spark Therapeutics) Product Table 92. Roche (Spark Therapeutics) Revenue in Gene Therapy for CNS Disorders Business (2015-2020) (Million US$) Table 93. Roche (Spark Therapeutics) Recent Development Table 94. Bluebird Bio Company Details Table 95. Bluebird Bio Business Overview Table 96. Bluebird Bio Product Table 97. Bluebird Bio Revenue in Gene Therapy for CNS Disorders Business (2015-2020) (Million US$) Table 98. Bluebird Bio Recent Development Table 99. Research Programs/Design for This Report Table 100. Key Data Information from Secondary Sources Table 101. Key Data Information from Primary Sources List of Figures Figure 1. Global Gene Therapy for CNS Disorders Market Share by Type: 2020 VS 2026 Figure 2. Ex Vivo Features Figure 3. In Vivo Features Figure 4. Global Gene Therapy for CNS Disorders Market Share by Application: 2020 VS 2026 Figure 5. Hospitals Case Studies Figure 6. Clinics Case Studies Figure 7. Others Case Studies Figure 8. Gene Therapy for CNS Disorders Report Years Considered Figure 9. Global Gene Therapy for CNS Disorders Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Gene Therapy for CNS Disorders Market Share by Regions: 2020 VS 2026 Figure 11. Global Gene Therapy for CNS Disorders Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Gene Therapy for CNS Disorders Market Share by Players in 2019 Figure 14. Global Top Gene Therapy for CNS Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for CNS Disorders as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy for CNS Disorders Revenue in 2019 Figure 16. North America Gene Therapy for CNS Disorders Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Gene Therapy for CNS Disorders Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China Gene Therapy for CNS Disorders Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan Gene Therapy for CNS Disorders Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia Gene Therapy for CNS Disorders Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India Gene Therapy for CNS Disorders Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America Gene Therapy for CNS Disorders Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Gilead (Kite Pharma) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Gilead (Kite Pharma) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2015-2020) Figure 25. Amgen (BioVex) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Amgen (BioVex) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2015-2020) Figure 27. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Novartis Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2015-2020) Figure 29. Roche (Spark Therapeutics) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Roche (Spark Therapeutics) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2015-2020) Figure 31. Bluebird Bio Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Bluebird Bio Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2015-2020) Figure 33. Bottom-up and Top-down Approaches for This Report Figure 34. Data Triangulation Figure 35. Key Executives Interviewed

Gilead (Kite Pharma) Amgen (BioVex) Novartis Roche (Spark Therapeutics) Bluebird Bio